此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes

2020年8月6日 更新者:Lindsay Mayberry、Vanderbilt University Medical Center
This study evaluates a mobile phone-delivered intervention, called REACH (Rapid Education/Encouragement And Communications for Health), in supporting adults with type 2 diabetes in their self-management relative to a control group. The goal of this study is to determine if individually tailored content (based on the Information-Motivation-Behavioral Skills Model) delivered to the participant via text messages can improve the participant's glycemic control and adherence to diabetes medications. We will test whether our intervention improves adherence-related information, motivation, and behavioral skills and whether improving these mechanisms drives improvements in adherence and, in turn, glycemic control.

研究概览

研究类型

介入性

注册 (实际的)

512

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Tennessee
      • Nashville、Tennessee、美国、37203
        • Federally Qualified Health Centers and Vanderbilt Primary Care Clinics

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Adults aged 18 years and older
  • Individuals who have received a diagnosis for type 2 diabetes mellitus
  • Enrolled as a patient at a participating community health center
  • Individuals currently being treated with oral and/or injectable diabetes medications

Exclusion Criteria:

  • Non-English speakers
  • Individuals who report they do not have a cell phone
  • Individuals unwilling and/or not able to provide written informed consent
  • Individuals with unintelligible speech (e.g., dysarthria)
  • Individuals with a severe hearing or visual impairment
  • Individuals who report a caregiver administers their diabetes medications Individuals who fail the cognitive screener administered during the baseline survey
  • Individuals who cannot receive, read, and respond to a text after instruction from a trained research assistant
  • Individuals whose most recent (within 12 months) HbA1c value was 6.8% or greater

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:REACH

Participants will receive REACH text messages (individual-focused text messaging tailored to user's individual barriers to adherence and targeted to address other self-care behaviors) for 12 months.

All participants will also receive text messages advising how to access their study A1c test results, receive quarterly newsletters on healthy living with diabetes, and have access to a Helpline for study- and diabetes medication-related questions.

The intervention consists of daily text messaging tailored to user's individual barriers to medication adherence, text messages assessing user's adherence with feedback on progress, plus text messaging targeting other self-care behaviors.
Participants complete study assessments, receive text messages advising how to access study A1c results, receive quarterly newsletters on healthy living with diabetes, and have access to a helpline for study- or diabetes medication-related questions.
实验性的:REACH + FAMS

In addition to the REACH text messages tailored to user's individual barriers to adherence, participants will receive FAMS components (monthly phone coaching and text messages supporting a goal set in coaching, plus the option to invite a family member/support person to receive text messages) for six months. After six months, participants in this arm will receive REACH text messages only.

All participants will also receive text messages advising how to access their study A1c test results, receive quarterly newsletters on healthy living with diabetes, and have access to a Helpline for study- and diabetes medication-related questions.

Participants complete study assessments, receive text messages advising how to access study A1c results, receive quarterly newsletters on healthy living with diabetes, and have access to a helpline for study- or diabetes medication-related questions.
The intervention consists of REACH individually-focused text messaging, plus family-focused phone coaching session, goal-focused text messaging, and the option to invite a family member/support person to receive text messaging.
其他名称:
  • NCT02481596
有源比较器:Helpline and A1c results

Participants assigned to the control group will complete measures at each time point and maintain care as usual (i.e., medical treatment and physician monitoring).

All participants will receive text messages advising how to access their study A1c test results, receive quarterly newsletters on healthy living with diabetes, and have access to a Helpline for study- and diabetes medication-related questions.

Participants complete study assessments, receive text messages advising how to access study A1c results, receive quarterly newsletters on healthy living with diabetes, and have access to a helpline for study- or diabetes medication-related questions.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Glycemic Control as Indicated by Hemoglobin A1c (HbA1c)
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
as measured by Hemoglobin A1c (%) with higher values indicating worse glycemic control and an improvement of 0.5% considered clinically meaningful
Baseline, 3 months, 6 months, 12 months, 15 months

次要结果测量

结果测量
措施说明
大体时间
Change in Self-reported Medication Adherence
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
as measured by the Summary of Diabetes Self-Care Activities (SDSCA) Medications subscale; response options are days in the last week ranging from 0 to 7, with 7 representing perfect adherence
Baseline, 3 months, 6 months, 12 months, 15 months
Change in Self-reported Medication Adherence
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
as measured by the Adherence to Refills and Medications Scale for Diabetes (ARMS-D); reverse coded such that higher scores indicate better adherence on a scale from 11 to 44
Baseline, 3 months, 6 months, 12 months, 15 months

其他结果措施

结果测量
措施说明
大体时间
Change in Adherence to Dietary Behavior
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
as measured by the Personal Diabetes Questionnaire diet subscale "Use of information for decision making"; possible range 1-6, higher indicates more use of dietary information (better)
Baseline, 3 months, 6 months, 12 months, 15 months
Change in Adherence to Dietary Behavior
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
Personal Diabetes Questionnaire diet subscale "Problem eating behavior"; possible range 1-6 with higher indicating more problem eating behavior (worse)
Baseline, 3 months, 6 months, 12 months, 15 months
Change in Physical Activity
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
as measured by International Physical Activity Questionnaire-Short form [metabolic equivalent minutes (MET-minutes) per week] where more MET-minutes per week indicates more physical activity
Baseline, 3 months, 6 months, 12 months, 15 months
Change in Glycemic Control - REACH Only vs. Control & REACH+FAMS vs. Control
大体时间:Baseline, 3 months, 6 months, 12 months, 15 months
as measured by hemoglobin A1c (HbA1c, %) We may be under-powered to for these comparative analyses.
Baseline, 3 months, 6 months, 12 months, 15 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Lindsay S Mayberry, MS, PhD、Vanderbilt University Medical Center

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2016年5月23日

初级完成 (实际的)

2019年6月4日

研究完成 (实际的)

2019年6月4日

研究注册日期

首次提交

2015年3月9日

首先提交符合 QC 标准的

2015年3月31日

首次发布 (估计)

2015年4月6日

研究记录更新

最后更新发布 (实际的)

2020年8月17日

上次提交的符合 QC 标准的更新

2020年8月6日

最后验证

2020年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • 140562
  • 1R01DK100694-01A1 (美国 NIH 拨款/合同)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Individual participant data collected during the trial will be de-identified and made available following publication of the 15-month trial results to researchers who provide a methodologically sound proposal.

IPD 共享时间框架

Beginning 6 months after final trial results publication. No end date.

IPD 共享访问标准

Approval of a proposal by the study PI.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

REACH的临床试验

3
订阅